Search Results 61-70 of 16494 for what is vedolizumab

  1. Crohn's disease - Doctors and departments - Mayo Clinic

    Mayo Clinic researchers are working to improve diagnosis and treatment of Crohn's disease. Radiologists at Mayo Clinic were instrumental in developing novel ...

  2. Ulcerative colitis - Care at Mayo Clinic

    Treating ulcerative colitis involves specialists in gastroenterology and hepatology, colon and rectal surgery, radiology, laboratory medicine and pathology, ...

  3. Mayo Clinic Q and A: Absence of treatment, Crohn’s disease tends to get worse over time

    Unlike ulcerative colitis (another inflammatory condition), Crohn's disease usually affects the entire thickness of the bowel wall. People with Crohn's disease ...

  4. Ulcerative colitis flare-ups: 5 tips to manage them - Mayo Clinic

    An ulcerative colitis flare-up is the return of symptoms after not having any for a period of time. This may involve diarrhea, belly pain and cramping, rectal ...

  5. Tofacitinib (oral route) - Mayo Clinic

    ... ulcerative colitis, ankylosing spondylitis, and polyarticular course juvenile idiopathic arthritis (pcJIA) in patients who have taken other medicines (eg ...

  6. Mirikizumab-mrkz (intravenous route, subcutaneous route) - Mayo Clinic

    For ulcerative colitis: Adults—The first 3 doses are given by a doctor through an IV catheter placed in one of your veins at Week 0, Week 4, and Week 8 ...

  7. Sulfasalazine (oral route) - Mayo Clinic

    For treatment of ulcerative colitis: For oral dosage form (enteric-coated tablets):. Adults—At first, 500 to 1000 milligrams (mg) every 6 to 8 ...

  8. Ustekinumab-ttwe (intravenous route, subcutaneous route) - Mayo Clinic

    Ustekinumab-ttwe injection is also used to treat moderate to severe active Crohn's disease and ulcerative colitis. This medicine is available only with your ...

  9. A Study to Collect Biospecimens (Blood, Stool and Intestinal Biopsies) to Support the Development of Specific Biomarkers of Treatment Response to Infliximab and Vedolizumab in Children with IBD - Mayo Clinic

    Ages 1-22 years · Diagnosis of Crohn's disease, ulcerative colitis or inflammatory bowel disease-unspecified who are referred to start infliximab or vedolizumab ...

  10. Ulcerative colitis - Doctors and departments - Mayo Clinic

    This type of inflammatory bowel disease affects the innermost lining of your digestive tract. Learn about available treatments for this often exhausting ...